About anti d rho immunoglobulin
Rh(D) immune globulin
Used for
- Prevents Rh sensitization in eligible Rh-negative pregnant people
- Treats immune thrombocytopenia in Rh-positive patients
- Prevents Rh sensitization after incompatible Rh-positive blood exposure
Usual adult dose
Pregnancy prevention: 300 micrograms at 28 weeks and within 72 hours after delivery if indicated. Other situations require product- and exposure-specific dosing.
Usual dose in children
Immune thrombocytopenia: 50–75 micrograms/kg intravenously as a single dose; specialist-directed.
Common side effects
- Headache, fever, chills, or nausea
- Injection-site pain or swelling
- Rare severe allergic reaction
- Rare hemolysis, including kidney injury
Important warnings
- Can cause red blood cell destruction; monitor for anemia and kidney problems
- Not for Rh-negative patients with immune thrombocytopenia
- Intravenous use for immune thrombocytopenia; route varies by indication
- May interfere with live-virus vaccine responses
Pregnancy
Used during pregnancy to prevent Rh sensitization when indicated; timing and dose depend on clinical circumstances.
Breastfeeding
Generally compatible; clinically significant transfer into breast milk is unlikely.
Interactions
- May reduce responses to live vaccines such as measles, mumps, rubella, and varicella
- Can interfere with blood typing and antibody test results
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.